Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Tillotson, Joni
and
Tillotson, Glenn S
2013.
Clostridium difficile: New Challenges for an Old Foe.
p.
140.
Nanwa, Natasha
Kendzerska, Tetyana
Krahn, Murray
Kwong, Jeffrey C
Daneman, Nick
Witteman, William
Mittmann, Nicole
Cadarette, Suzanne M
Rosella, Laura
and
Sander, Beate
2015.
The Economic Impact of Clostridium difficile Infection: A Systematic Review.
American Journal of Gastroenterology,
Vol. 110,
Issue. 4,
p.
511.
Nelson, Richard E.
Nelson, Scott D.
Khader, Karim
Perencevich, Eli L.
Schweizer, Marin L.
Rubin, Michael A.
Graves, Nicholas
Harbarth, Stephan
Stevens, Vanessa W.
and
Samore, Matthew H.
2015.
The Magnitude of Time-Dependent Bias in the Estimation of Excess Length of Stay Attributable to Healthcare-Associated Infections.
Infection Control & Hospital Epidemiology,
Vol. 36,
Issue. 9,
p.
1089.
Pakyz, Amy L.
Patterson, Julie A.
Motzkus-Feagans, Christine
Hohmann, Samuel F.
Edmond, Michael B.
and
Lapane, Kate L.
2015.
Performance of the Present-on-Admission Indicator for Clostridium difficile Infection.
Infection Control & Hospital Epidemiology,
Vol. 36,
Issue. 7,
p.
838.
Zhang, Shanshan
Palazuelos-Munoz, Sarah
Balsells, Evelyn M.
Nair, Harish
Chit, Ayman
and
Kyaw, Moe H.
2016.
Cost of hospital management of Clostridium difficile infection in United States—a meta-analysis and modelling study.
BMC Infectious Diseases,
Vol. 16,
Issue. 1,
Leal, Jenine R.
Conly, John
Weaver, Robert
Wick, James
Henderson, Elizabeth A.
Manns, Braden
and
Ronksley, Paul
2019.
Attributable costs and length of stay of hospital-acquired Clostridioides difficile: A population-based matched cohort study in Alberta, Canada.
Infection Control & Hospital Epidemiology,
Vol. 40,
Issue. 10,
p.
1135.
Balsells, Evelyn
Shi, Ting
Leese, Callum
Lyell, Iona
Burrows, John
Wiuff, Camilla
Campbell, Harry
Kyaw, Moe H
and
Nair, Harish
2019.
Global burden of Clostridium difficile infections: a systematic review and meta-analysis.
Journal of Global Health,
Vol. 9,
Issue. 1,
Marra, Alexandre R.
Perencevich, Eli N.
Nelson, Richard E.
Samore, Matthew
Khader, Karim
Chiang, Hsiu-Yin
Chorazy, Margaret L.
Herwaldt, Loreen A.
Diekema, Daniel J.
Kuxhausen, Michelle F.
Blevins, Amy
Ward, Melissa A.
McDanel, Jennifer S.
Nair, Rajeshwari
Balkenende, Erin
and
Schweizer, Marin L.
2020.
Incidence and Outcomes Associated WithClostridium difficileInfections.
JAMA Network Open,
Vol. 3,
Issue. 1,
p.
e1917597.
Nelson, Richard E
Goto, Michihiko
Samore, Matthew H
Jones, Makoto
Stevens, Vanessa W
Evans, Martin E
Schweizer, Marin L
Perencevich, Eli N
and
Rubin, Michael A
2021.
Expanding an Economic Evaluation of the Veterans Affairs (VA) Methicillin-resistantStaphylococcus aureus(MRSA) Prevention Initiative to Include Prevention of Infections From Other Pathogens.
Clinical Infectious Diseases,
Vol. 72,
Issue. Supplement_1,
p.
S50.
Son, K.J.
Kim, Y.A.
and
Park, Y.S.
2022.
Economic burden attributable to Clostridioides difficile infections in South Korea: a nationwide propensity score-matched study.
Journal of Hospital Infection,
Vol. 120,
Issue. ,
p.
1.
Currie, Dustin W.
Lewis, Chantal
Lutgring, Joseph D.
Kazakova, Sophia V.
Baggs, James
Korhonen, Lauren
Correa, Maria
Goodenough, Dana
Olson, Danyel M.
Szydlowski, Jill
Dumyati, Ghinwa
Fridkin, Scott K.
Wilson, Christopher
Guh, Alice Y.
Reddy, Sujan C.
and
Hatfield, Kelly M.
2025.
Comparison of Medicare claims-based Clostridioides difficile infection epidemiologic case classification algorithms to medical record review by the Emerging Infections Program using a linked cohort, 2016–2021.
Infection Control & Hospital Epidemiology,
p.
1.